ON-TARGETplus Non-targeting Control siRNAs


Negative control siRNAs designed and microarray tested for minimal targeting of human, mouse, or rat genes. ON-TARGETplus modifications reduce potential off-targets. Recommended for determination of baseline cellular responses in RNAi experiments.
ON-TARGETplus Non-targeting Control siRNAs are the ideal negative control for RNAi experiments in human, mouse, and rat cells.  ON-TARGETplus Non-targeting siRNAs were designed to leverage seed-region optimization and patented ON-TARGETplus modification patterns to have fewer off-targets than traditionally designed, unmodified negative control siRNAs. Changes in mRNA or protein levels in cells treated with these controls reflect a baseline cellular response that can be compared to the levels in cells treated with target-specific siRNA.

Highlights

  • Ideal negative control for RNAi experiments in human, mouse, and rat cells
  • Chemically matched for use with ON-TARGETplus siRNA reagents
  • Screened by genomewide microarray analysis to verify minimal off-targets
  
HazardousNo
Shipping ConditionAmbient
Stability at Recommended Storage ConditionsAt least 12 months
Storage Condition-20 C
ON-TARGETplus Non-targeting controls have reduced off-targets

ON-TARGETplus Non-targeting controls have reduced off-targets

ON-TARGETplus Non-targeting controls have reduced off-targets

RNA samples from HeLa cells were analyzed by microarray expression profiling 24 hours after transfection with the indicated siRNA reagents. Decreases in mRNA levels are shown in green and increases in red. The left panel shows a typical off-target signature of a “Scramble” control siRNA. The right panel shows the off-targets for ON-TARGETplus Non-Targeting Control siRNAs 1 through 4. (D-001810-01, -02, 03, 04).


Citations

  1. P. Baum, K. Fundel-Clemens, S. Kreuz, R. E. Kontermann, A. Weith, D. Mennerich, J. F. Rippmann. Off-Target Analysis of Control siRNA Molecules Reveals Important Differences in the Cytokine Profile and Inflammation Response of Human Fibroblasts. Oligonucleotides. 20(1), 17-25 (2010).